Summary
Commonly reported side effects of bimatoprost ophthalmic include: hypertrichosis of eyelid. Continue reading for a comprehensive list of adverse effects.
Applies to bimatoprost ophthalmic: implant, solution.
Serious side effects
Along with its needed effects, bimatoprost ophthalmic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking bimatoprost ophthalmic:
Less common
- Blindness
- bloody eye
- blurred or decreased vision
- change in color vision
- color changes in the skin around the eyes
- difficulty seeing at night
- disturbed color perception
- double vision
- dry eyes
- eye color changes
- fever or chills
- halos around lights
- lack or loss of strength
- loss of vision
- night blindness
- overbright appearance of lights
- redness, burning, dry, or itching eyes
- redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid
- tunnel vision
Other side effects
Some side effects of bimatoprost ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Body aches or pain
- cough
- difficulty with breathing
- ear congestion
- headache
- loss of voice
- nasal congestion
- redness of the white part of eyes or inside of the eyelids
- runny nose
- sneezing
- sore throat
- unusual tiredness or weakness
Less common
- Darkening of the eyelashes
- eye discharge or excessive tearing
- eye strain
- feeling of having something in the eye
- increase in hair growth
- increased sensitivity of the eyes to sunlight
For Healthcare Professionals
Applies to bimatoprost ophthalmic: intraocular implant, ophthalmic solution.
General
The most frequently reported adverse reactions were eyelash growth, conjunctival hyperemia, and ocular pruritus.[Ref]
Ocular
Corneal calcification occurred in patients with significant corneal damage using formulations containing phosphate.[Ref]
Very common (10% or more): Growth of eyelashes (up to 45%), conjunctival hyperemia (up to 44%), ocular pruritus (up to 15%)
Common (1% to 10%): Allergic conjunctivitis, asthenopia, blepharitis, blurred vision, cataract, conjunctival edema, conjunctival hemorrhage, corneal erosion, dry eye, eye discharge, eye irritation, eye pain, eye pruritus, eyelash darkening, eyelid pruritus, foreign body sensation, increased iris pigmentation, lacrimation increased, ocular burning, ocular dryness, ocular irritation, photophobia, punctate keratitis, superficial punctate keratitis, tearing, visual disturbance, worsening of visual acuity
Uncommon (0.1% to 1%): Blepharospasm, eyelid edema, eyelid margin crusting, eyelid retraction, iris hyperpigmentation, iritis, retinal hemorrhage, uveitis
Rare (0.01% to 0.1%): Corneal calcification
Frequency not reported: Blepharal pigmentation, cystoid macular edema, eye edema, eyelash changes, eyelid sulcus deepening, intraocular inflammation, macular edema, signs/symptoms of eye allergy
Postmarketing reports: Enophthalmos[Ref]
Dermatologic
Common (1% to 10%): Eyelid erythema, hirsutism, hypertrichosis, periocular skin hyperpigmentation, periorbital erythema, pigmentation of periocular skin, skin hyperpigmentation
Uncommon (0.1% to 1%): Abnormal hair growth, dry skin, madarosis, pruritus
Frequency not reported: Lid changes, periorbital changes, pigmentation, signs/symptoms of allergic dermatitis[Ref]
Immunologic
Common (1% to 10%): Colds, infections[Ref]
Respiratory
Common (1% to 10%): Upper respiratory tract infections
Frequency not reported: Asthma, asthma exacerbation, chronic obstructive pulmonary disease (COPD) exacerbation, dyspnea
Postmarketing reports: Asthma-like symptoms[Ref]
Nervous system
Common (1% to 10%): Headache
Uncommon (0.1% to 1%): Dizziness, vertigo[Ref]
Local
Common (1% to 10%): Instillation site irritation[Ref]
Hepatic
Common (1% to 10%): Abnormal liver function tests[Ref]
Other
Uncommon (0.1% to 1%): Asthenia[Ref]
Cardiovascular
Common (1% to 10%): Hypertension[Ref]
Gastrointestinal
Uncommon (0.1% to 1%): Nausea[Ref]
Psychiatric
Uncommon (0.1% to 1%): Depression[Ref]
Hypersensitivity
Frequency not reported: Hypersensitivity, hypersensitivity reaction[Ref]